Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis

Matthew L. Meizlish, George Goshua, Yiwen Liu, Rebecca Fine, Kejal Amin, Eric Chang, Nicholas DeFilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Wang, Christina Price, Robert D. Bona, Cassius Iyad Ochoa Chaar, Hyung J. Chun, Alexander B. Pine, Henry M. Rinder, Jonathan Siner, Donna S. Neuberg, Kent A. Owusu, Alfred Ian Lee
doi: https://doi.org/10.1101/2021.01.12.21249577

Article Information

doi 
https://doi.org/10.1101/2021.01.12.21249577
History 
  • January 15, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Matthew L. Meizlish, M.Phil.1,‡,
  2. George Goshua, M.D.2,‡,
  3. Yiwen Liu, M.S.3,‡,
  4. Rebecca Fine, M.D.4,‡,
  5. Kejal Amin, Pharm.D., M.B.A.5,
  6. Eric Chang, M.D.2,
  7. Nicholas DeFilippo5,6,
  8. Craig Keating7,
  9. Yuxin Liu, M.D.2,
  10. Michael Mankbadi, M.D.4,
  11. Dayna McManus, Pharm.D.5,
  12. Stephen Wang, M.D., M.P.H.4,
  13. Christina Price, M.D.8,
  14. Robert D. Bona, M.D.2,
  15. Cassius Iyad Ochoa Chaar, M.D., M.S.9,
  16. Hyung J. Chun, M.D.10,
  17. Alexander B. Pine, M.D., Ph.D.2,
  18. Henry M. Rinder, M.D.2,11,
  19. Jonathan Siner, M.D.12,
  20. Donna S. Neuberg, Sc.D.3,œ,*,
  21. Kent A. Owusu, Pharm.D.5,13,œ,* and
  22. Alfred Ian Lee, M.D., Ph.D.2,œ,*
  1. 1Yale School of Medicine, New Haven, CT
  2. 2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
  3. 3Dana-Farber Cancer Institute, Boston, MA
  4. 4Department of Medicine, Yale School of Medicine, New Haven, CT
  5. 5Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT
  6. 6School of Pharmacy, University of Connecticut, Storrs, CT
  7. 7Joint Data Analytics Team, Yale New Haven Hospital, New Haven, CT
  8. 8Section of Allergy and Immunology, Department of Medicine, Yale School of Medicine, New Haven, CT
  9. 9Section of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT
  10. 10Section of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT
  11. 11Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT
  12. 12Section of Pulmonary and Sleep Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT
  13. 13Clinical Redesign, Yale New Haven Health, New Haven, CT
  1. ↵*Corresponding authors: Alfred Ian Lee, M.D., PhD. (alfred.lee{at}yale.edu); Kent Owusu, Pharm.D. (kent.owusu{at}ynhh.org); Donna S. Neuberg, Sc.D. (neuberg{at}ds.dfci.harvard.edu)

  1. ↵‡ Contributed equally as first authors.

  2. ↵œ Contributed equally as senior authors.

Back to top
Posted January 15, 2021.
Download PDF
Data/Code
Email
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis
Matthew L. Meizlish, George Goshua, Yiwen Liu, Rebecca Fine, Kejal Amin, Eric Chang, Nicholas DeFilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Wang, Christina Price, Robert D. Bona, Cassius Iyad Ochoa Chaar, Hyung J. Chun, Alexander B. Pine, Henry M. Rinder, Jonathan Siner, Donna S. Neuberg, Kent A. Owusu, Alfred Ian Lee
medRxiv 2021.01.12.21249577; doi: https://doi.org/10.1101/2021.01.12.21249577
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area